Ligand Pharmaceuticals Inc (LGND) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

By Yahoo! Finance | Nov 8, 2024 at 02:17 AM EST

Ligand is considering 25 potential investments, including project finance deals and M&A opportunities. Filspa by Travere aims to treat IgA nephropathy and FSGS with promising data. Ligand is well-staffed and prepared for growth, with no immediate buyback plans.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.